Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Caladrius Bio (NQ: CLBS )

1.540 USD +0.050 (+3.36%)
Streaming Delayed Price Updated: 1:41 PM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Caladrius Bio

< Previous 1 2 3 4 5 6 7 8 Next >
Mid-Morning Market Update: Markets Open Higher; AutoZone Beats Q3 Expectations
Following the market opening Tuesday, the Dow traded up 2.29% to 25024.78 while the NASDAQ rose 1.38% to 9453.15. The S&P also rose, ... 
Tags AZO News MTG
From Benzinga
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From GlobeNewswire News Releases
We Did The Math VXF Can Go To $123
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
20 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers • Tetraphase Pharmaceutical, Inc. (NASDAQ:TTPH) stock moved upwards by 62.20% to $2.66 during Friday's pre-market ... 
Tags OBLN BNGO Markets
From Benzinga
60 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares surged 71.1% to close at $15.21 on Thursday after the company announced ... 
Tags UNFI CSCO ALLO
From Benzinga
Caladrius Biosciences Reports Positive Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions
Single administration of CLBS16 durably improves heart function and symptoms in patients with coronary microvascular dysfunction 
From GlobeNewswire News Releases
The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags VRML ASCO BLFS
From Benzinga
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares ... 
Tags GILD EYEN INFI
From Benzinga
Penny Stocks To Buy Or Sell Right Now; What Do Analysts Think?
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
From GlobeNewswire News Releases
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags ACAD GKOS HZNP
From Benzinga
Caladrius Biosciences Announces Presentation of Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions
From GlobeNewswire News Releases
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags NTLA ISEE CALA
From Benzinga
Caladrius Biosciences to Host First Quarter 2020 Financial Results Conference Call on Thursday, May 7, 2020
From GlobeNewswire News Releases
Caladrius Biosciences Closes $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From GlobeNewswire News Releases
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From GlobeNewswire News Releases
Caladrius Biosciences Plans to Assess its CLBS119 Cell Therapy for Repair of COVID-19 Induced Lung Damage
FDA authorizes new IND for the study of CLBS119 in COVID-19 patients who experienced respiratory failure 
From GlobeNewswire News Releases
Caladrius Biosciences to Receive $10.9 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program
From GlobeNewswire News Releases
Look Under The Hood: VTI Has 17% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags BBI ACRS PLXP
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday morning, 1178 companies hit new 52-week lows. Facts of Interest: The largest company by market cap to set a new ... 
Tags HIX THRM ROLL
From Benzinga
Memgen Appoints Gregory Brown as Chief Executive Officer
From Newsfile Corp News Releases
Memgen Appoints Gregory Brown as Chief Executive Officer
Tags Pharmaceuticals and Biotech
From Latest Press Releases from Newswire.com
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
From GlobeNewswire News Releases
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SWTX IBB ANGO
From Benzinga
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 ... 
Tags ZGNX News Benzinga
From Benzinga
Caladrius Biosciences to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Thursday, March 5, 2020 at 4:30 p.m. Eastern Time
From GlobeNewswire News Releases
Caladrius Biosciences to Participate at Upcoming February Conferences
From GlobeNewswire News Releases
55 Biggest Movers From Friday
Gainers CounterPath, Corp. (NASDAQ: CPAH) shares jumped 304.1% to close at $3.92 on Friday after the company partnered with ... 
Tags BTAI SNX SSI
From Benzinga
Caladrius Biosciences to Participate at Upcoming January Conferences
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.